Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trial.
T M L TongM K van der KooijF M SpeetjensA R van ErkelR W van der MeerJ LutjeboerE L van Persijn van MeertenC H MartiniR W M ZoethoutF G J TijlC U BlankM C BurgmansE KapiteijnPublished in: Trials (2022)
This trial was registered in the US National Library of Medicine with identifier NCT04283890 . Registered as per February 2020 - Retrospectively registered. EudraCT registration number: 2018-004248-49. Local MREC registration number: NL60508.058.19.